Hall & Partners

Hall & Partners provides strategic insight and market research services to pharmaceutical, biotech, device and diagnostic companies as well as healthcare systems and patient advocacy groups. They help clients with brand strategy, campaign effectiveness, and market access across the clinical, medical and commercial lifecycle. Their work has supported 18 of the top 20 biopharmaceutical companies in areas such as brand performance tracking and disease state awareness campaigns. They are recognized for combining behavioral science with advanced analytics to deliver actionable insights that drive decision-making in pharma/biotech. The company was acquired by Escalent in 2023. No clinical results or pipeline programs exist since they are not a drug developer.